Real world retrospective study of Olaparib in recurrent platinum sensitive ovarian cancer
Latest Information Update: 18 Nov 2019
At a glance
- Drugs Olaparib (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 18 Nov 2019 New trial record
- 04 Nov 2019 Results (Data cut off;31 May 2019) published in the Gynecologic Oncology.